医学
叶黄素
倾向得分匹配
胰腺导管腺癌
新辅助治疗
外科
胰腺切除术
胰腺癌
切除术
内科学
癌症
乳腺癌
奥沙利铂
结直肠癌
作者
Guoliang Qiao,Zhi Ven Fong,Louisa Bolm,Carlos Fernandez del-Castillo,Cristina R. Ferrone,Maximiliano Servín-Rojas,Priyadarshini Pathak,Kelsey S. Lau‐Min,Jill N. Allen,Lawrence S. Blaszkowsky,Jeffrey W. Clark,Aparna R. Parikh,David P. Ryan,Colin D. Weekes,Hannah M. Roberts,Jennifer Y. Wo,Theodore S. Hong,Keith D. Lillemoe,Motaz Qadan
出处
期刊:Annals of Surgery
[Ovid Technologies (Wolters Kluwer)]
日期:2023-10-13
卷期号:280 (1): 118-125
标识
DOI:10.1097/sla.0000000000006131
摘要
To evaluate the safety and efficacy of neoadjuvant therapy (NAT), followed by surgical resection in patients with pancreatic ductal adenocarcinoma (PDAC) aged ≥75 years.
科研通智能强力驱动
Strongly Powered by AbleSci AI